Modulation of Fas-FasL related apoptosis by PBN in the early phases of choline deficient diet-mediated hepatocarcinogenesis in rats

References

• Copeland D, Salmon WD. The occurrence of neoplasms in the liver, lungs, and other tissues of rats as a result of prolonged choline deficiency. Am J Path 1946; 22: 1059–1079
   PubMed Web of Science ®Google Scholar
• Nakae D, Yoshiji H, Maruyama H, Kinugasa T, Denda A, Konishi Y. Production of both 8-hydroxydeoxyguanosine in liver DNA and gamma-glutamyltransferase-positive hepatocellular lesions in rats given a choline-deficient, L-amino acid-defined diet. Jpn J Cancer Res 1990; 81: 1081–1084
   PubMedGoogle Scholar
• Asada, K, Kotake, Y, Asada, R, Saunders, D, Broyles, RH, Towner, RA, Fukui, H, Floyd, RA. LINE-1 hypomethylation in a choline-deficiency-induced liver cancer in rats: dependence on feeding period. J Biomed Biotechnol 2006;1:17142.
   Google Scholar
• Poirier LA. The effects of diet, genetics and chemicals on toxicity and aberrant DNA methylation: an introduction. J Nutr 2002; 132: 2336S–2339S
   Google Scholar
• Christman JK. Lipotrope deficiency and persistent changes in DNA methylation. Lipotrope deficiency and DNA methylation. Adv Exp Med Biol 1995; 375: 97–106
   PubMedGoogle Scholar
• Rushmore TH, Farber E, Ghoshal AK, Parodi S, Pala M, Taningher M. A choline-devoid diet, carcinogenic in the rat, induces DNA damage and repair. Carcinogenesis 1986; 7: 1677–1680
   PubMed Web of Science ®Google Scholar
• Tsujiuchi T, Kobayashi E, Nakae D, Mizumoto Y, Andoh N, Kitada H, Ohashi K, Fukuda T, Kido A, Tsutsumi M, Denda A, Konishi Y. Prevention by methionine of enhancement of hepatocarcinogenesis by coadministration of a choline-deficient L-amino acid-defined diet and ethionine in rats. Jpn J Cancer Res 1995; 86: 1136–1142
   PubMedGoogle Scholar
• Yen CL, Mar MH, Zeisel SH. Choline deficiency-induced apoptosis in PC12 cells is associated with diminished membrane phosphatidylcholine and sphingomyelin, accumulation of ceramide and diacylglycerol, and activation of a caspase. Faseb J 1999; 13: 135–42
   PubMed Web of Science ®Google Scholar
• Nakae D, Kotake Y, Kishida H, Hensley KL, Denda A, Kobayashi Y, Kitayama W, Tsujiuchi T, Sang H, Stewart CA, Tabatabaie T, Floyd RA, Konishi Y. Inhibition by phenyl N-tert-butyl nitrone of early phase carcinogenesis in the livers of rats fed a choline-deficient, L-amino acid-defined diet. Cancer Res 1998; 58: 4548–4551
   PubMed Web of Science ®Google Scholar
• Eastin CE, McClain CJ, Lee EY, Bagby GJ, Chawla RK. Choline deficiency augments and antibody to tumor necrosis factor-alpha attenuates endotoxin-induced hepatic injury. Alcohol Clin Exp Res 1997; 21: 1037–1041
   PubMedGoogle Scholar
• Zeisel SH, Albright CD, Shin OH, Mar MH, Salganik RI, da Costa KA. Choline deficiency selects for resistance to p53-independent apoptosis and causes tumorigenic transformation of rat hepatocytes. Carcinogenesis 1997; 18: 731–738
   PubMed Web of Science ®Google Scholar
• da Costa KA, Cochary EF, Blusztajn JK, Garner SC, Zeisel SH. Accumulation of 1,2-sn-diradylglycerol with increased membrane-associated protein kinase C may be the mechanism for spontaneous hepatocarcinogenesis in choline-deficient rats. J Biol Chem 1993; 268: 2100–2105
   PubMedGoogle Scholar
• Shinozuka H, Katyal SL, Perera MI. Choline deficiency and chemical carcinogenesis. Adv Exp Med Biol 1986; 206: 253–267
   PubMedGoogle Scholar
• Holmes-McNary MQ, Baldwin AS, Jr, Zeisel SH. Opposing regulation of choline deficiency-induced apoptosis by p53 and nuclear factor kappaB. J Biol Chem 2001; 276: 41197–41204
   PubMedGoogle Scholar
• Nakae D. Endogenous liver carcinogenesis in the rat. Pathol Int 1999; 49: 1028–1042
   PubMed Web of Science ®Google Scholar
• Kotake Y, Kishida H, Nakae D, Floyd RA. Nitric oxide production by primary liver cells isolated from amino acid diet-fed rats. Methods Enzymol 2005; 396: 535–541
   PubMed Web of Science ®Google Scholar
• Chen GG, Lau WY, Lai PB, Chun YS, Chak EC, Leung BC, Lam IK, Lee JF, Chui AK. Activation of Kupffer cells inhibits tumor growth in a murine model system. Int J Cancer 2002; 99: 713–720
   PubMed Web of Science ®Google Scholar
• Lala PK, Orucevic A. Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev 1998; 17: 91–106
   PubMed Web of Science ®Google Scholar
• Thomsen LL, Miles DW. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev 1998; 17: 107–118
   PubMed Web of Science ®Google Scholar
• Young MR, Wright MA, Matthews JP, Malik I, Prechel M. Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide. J Immunol 1996; 156: 1916–1922
   PubMedGoogle Scholar
• Denda A, Tang Q, Endoh T, Tsujiuchi T, Horiguchi K, Noguchi O, Mizumoto Y, Nakae D, Konishi Y. Prevention by acetylsalicylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L-amino acid-defined diet in rats. Carcinogenesis 1994; 15: 1279–1283
   PubMedGoogle Scholar
• Nakae D, Uematsu F, Kishida H, Kusuoka O, Katsuda S, Yoshida M, Takahashi M, Maekawa A, Denda A, Konishi Y, Kotake Y, Floyd RA. Inhibition of the development of hepatocellular carcinomas by phenyl N-tert-butyl nitrone in rats fed with a choline-deficient, L-amino acid-defined diet. Cancer Lett 2004; 206: 1–13
   PubMed Web of Science ®Google Scholar
• Floyd RA, Kotake Y, Hensley K, Nakae D, Konishi Y. Reactive oxygen species in choline deficiency induced carcinogenesis and nitrone inhibition. Mol Cell Biochem 2002; 234–235: 195–203
   PubMed Web of Science ®Google Scholar
• Kotake Y. Pharmacologic properties of phenyl N-tert-butylnitrone. Antioxid Redox Signal 1999; 1: 481–499
   PubMed Web of Science ®Google Scholar
• Floyd RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999; 222: 236–245
   PubMed Web of Science ®Google Scholar
• Miyajima T, Kotake Y. Spin trapping agent, phenyl N-tert-butyl nitrone, inhibits induction of nitric oxide synthase in endotoxin-induced shock in mice. Biochem Biophys Res Commun 1995; 215: 114–121
   PubMed Web of Science ®Google Scholar
• Sang H, Wallis GL, Stewart CA, Kotake Y. Expression of cytokines and activation of transcription factors in lipopolysaccharide-administered rats and their inhibition by phenyl N-tert-butylnitrone (PBN). Arch Biochem Biophys 1999; 363: 341–348
   PubMed Web of Science ®Google Scholar
• Kotake Y, Sang H, Miyajima T, Wallis GL. Inhibition of NF-kappaB, iNOS mRNA, COX2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN). Biochim Biophys Acta 1998; 1448: 77–84
   PubMed Web of Science ®Google Scholar
• Tsuji M, Inanami O, Kuwabara M. Neuroprotective effect of alpha-phenyl-N-tert-butylnitrone in gerbil hippocampus is mediated by the mitogen-activated protein kinase pathway and heat shock proteins. Neurosci Lett 2000; 282: 41–44
   PubMed Web of Science ®Google Scholar
• Nakae D, Kishida H, Enami T, Konishi Y, Hensley KL, Floyd RA, Kotake Y. Effects of phenyl N-tert-butyl nitrone and its derivatives on the early phase of hepatocarcinogenesis in rats fed a choline-deficient, L-amino acid-defined diet. Cancer Sci 2003; 94: 26–31
   PubMed Web of Science ®Google Scholar
• Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003; 125: 437–443
   PubMed Web of Science ®Google Scholar
• Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 2001; 34: 248–253
   PubMed Web of Science ®Google Scholar
• Ribeiro PS, Cortez-Pinto H, Sola S, Castro RE, Ramalho RM, Baptista A, Moura MC, Camilo ME, Rodrigues CM. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 2004; 99: 1708–1717
   PubMed Web of Science ®Google Scholar
• Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria in steatohepatitis. Semin Liver Dis 2001; 21: 57–69
   PubMed Web of Science ®Google Scholar
• Janzen EGSpin trapping. Acc Chem Res 1971;4:31–37.
   Web of Science ®Google Scholar
• Nagaoka S, Kamuro H, Oda H, Yoshida A. Effects of polychlorinated biphenyls on cholesterol and ascorbic acid metabolism in primary cultured rat hepatocytes. Biochem Pharmacol 1991; 41: 1259–1261
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Mars WM, Runge D, Kim TH, Bowen WC, Michalopoulos GK. Phenobarbital suppresses growth and accelerates restoration of differentiation markers of primary culture rat hepatocytes in the chemically defined hepatocyte growth medium containing hepatocyte growth factor and epidermal growth factor. Exp Cell Res 1998; 241: 445–457
   PubMedGoogle Scholar
• Mitsiades CS, Poulaki V, Fanourakis G, Sozopoulos E, McMillin D, Wen Z, Voutsinas G, Tseleni-Balafouta S, Mitsiades N. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation. Clin Cancer Res 2006; 12: 3705–3712
   PubMed Web of Science ®Google Scholar
• Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935–946
   PubMed Web of Science ®Google Scholar
• Desbarats J, Birge RB, Mimouni-Rongy M, Weinstein DE, Palerme JS, Newell MK. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol 2003; 5: 118–125
   PubMed Web of Science ®Google Scholar
• Wajant H, Pfizenmaier K, Scheurich P. Non-apoptotic Fas signaling. Cytokine Growth Factor Rev 2003; 14: 53–66
   PubMedGoogle Scholar
• Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet 1999; 33: 29–55
   PubMed Web of Science ®Google Scholar
• Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491–501
   PubMed Web of Science ®Google Scholar
• Kotamraju S, Konorev EA, Joseph J, Kalyanaraman B. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem 2000; 275: 33585–33592
   PubMed Web of Science ®Google Scholar
• Tomita H, Kotake Y, Anderson RE. Mechanism of protection from light-induced retinal degeneration by the synthetic antioxidant phenyl-N-tert-butylnitrone. Invest Ophthalmol Vis Sci 2005; 46: 427–434
   PubMedGoogle Scholar
• Lee JH, Park JW. The effect of α-phenyl-N-t-butyl nitrone on ionizing radiation-induced apoptosis in U937 cells. Free Radic Res 2005; 39: 1325–1333
   PubMed Web of Science ®Google Scholar
• Busciglio J, Pelsman A, Helguera P, Ashur-Fabian O, Pinhasov A, Brenneman DE, Gozes I. NAP and ADNF-9 protect normal and Down's syndrome cortical neurons from oxidative damage and apoptosis. Curr Pharm Des 2007; 13: 1091–1098
   PubMed Web of Science ®Google Scholar
• Ramadan M, Gamal-Eldeen AM, Abdel-Aziz M, Abuo-Rahma Gel D, Abdel-Nabi H, Nagib AH. C-(2-chloroquinoline-3-yl)-N-phenyl nitrone: new synthetic antioxidant inhibits proliferation and induces apoptosis of breast carcinoma MCF-7 cells. Arch Pharm (Weinheim) 2006; 339: 242–249
   PubMedGoogle Scholar
• Davies RA, Knight B, Tian YW, Yeoh GC, Olynyk JK. Hepatic oval cell response to the choline-deficient, ethionine supplemented model of murine liver injury is attenuated by the administration of a cyclo-oxygenase 2 inhibitor. Carcinogenesis 2006; 27: 1607–1616
   PubMedGoogle Scholar
• Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006; 44: 27–33
   PubMed Web of Science ®Google Scholar
• El-Bassiouni A, Nosseir M, Zoheiry M, El-Ahwany E, Ghali A, El-Bassiouni N. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma. Apmis 2006; 114: 420–427
   PubMedGoogle Scholar